In many organs, including the intestine and skin, cancers originate from cells of the stem or progenitor compartment. Despite its nomenclature, the cellular origin of hepatocellular carcinoma (HCC) remains elusive. In contrast to most organs, the liver lacks a defined stem cell population for organ maintenance. Previous studies suggest that both hepatocytes and facultative progenitor cells within the biliary compartment are capable of generating HCC. As HCCs with a progenitor signature carry a worse prognosis, understanding the origin of HCC is of clinical relevance. Here, we used complementary fate-tracing approaches to label the progenitor/biliary compartment and hepatocytes in murine hepatocarcinogenesis. In genotoxic and genetic models, HCCs arose exclusively from hepatocytes but never from the progenitor/biliary compartment. Cytokeratin 19–, A6- and α-fetoprotein–positive cells within tumors were hepatocyte derived. In summary, hepatocytes represent the cell of origin for HCC in mice, and a progenitor signature does not reflect progenitor origin, but dedifferentiation of hepatocyte-derived tumor cells.
Xueru Mu, Regina Español-Suñer, Ingmar Mederacke, Silvia Affò, Rita Manco, Christine Sempoux, Frédéric P. Lemaigre, Arlind Adili, Detian Yuan, Achim Weber, Kristian Unger, Mathias Heikenwälder, Isabelle A. Leclercq, Robert F. Schwabe
Title and authors | Publication | Year |
---|---|---|
Folliculin depletion results in liver cell damage and cholangiocarcinoma through MiT/TFE activation.
Custode BM, Annunziata F, Dos Santos Matos F, Schiano V, Maffia V, Lillo M, Colonna R, De Cegli R, Ballabio A, Pastore N |
Cell death and differentiation | 2025 |
Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs.
Bhartiya D, Raouf S, Pansare K, Tripathi A, Tripathi A |
Stem Cell Reviews and Reports | 2024 |
Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.
Ma Y, Lv H, Xing F, Xiang W, Wu Z, Feng Q, Wang H, Yang W |
Frontiers of Medicine | 2024 |
Single‐cell multi‐modal chromatin profiles revealing epigenetic regulations of cells in hepatocellular carcinoma
Wang C, Huang W, Zhong Y, Zou X, Liu S, Li J, Sun Y, Zhou K, Chen X, Li Z, Wang S, Huang Y, Bai Y, Yin J, Jin X, Liu S, Yuan Y, Deng Q, Jiang M, Liu C, Liu L, Xu X, Wu L |
Clinical and Translational Medicine | 2024 |
Aberrant differentiation and proliferation of hepatocytes in chronic liver injury and liver tumors.
Nishikawa Y |
Pathology international | 2024 |
Current status and new directions for hepatocellular carcinoma diagnosis
Tu J, Wang B, Wang X, Huo K, Hu W, Zhang R, Li J, Zhu S, Liang Q, Han S |
Liver Research | 2024 |
Monocyte-derived macrophages orchestrate multiple cell types to repair necrotic liver lesions
Dechun Feng, Xiaogang Xiang, Yukun Guan, Adrien Guillot, Hongkun Lu, Chingwen Chang, Yong He, Hua Wang, Hongna Pan, Cynthia Ju, Sean Colgan, Frank Tacke, XinWei Wang, George Kunos, Bin Gao |
Journal of Clinical Investigation | 2023 |
Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination
Gromowski T, Lukacs-Kornek V, Cisowski J |
Cancer Cell International | 2023 |
Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma
Hu X, Wang Q, Huang G, He X, Sparrelid E, Brismar TB, Fan Y |
Computational and mathematical methods in medicine | 2023 |
Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease
van Son KC, Verschuren L, Hanemaaijer R, Reeves H, Takkenberg RB, Drenth JP, Tushuizen ME, Holleboom AG |
Cancers | 2023 |
The Role of the Ectopeptidase APN/CD13 in Cancer
Lendeckel U, Karimi F, Al Abdulla R, Wolke C |
Biomedicines | 2023 |
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Kouroumalis E, Tsomidis I, Voumvouraki A |
Biomedicines | 2023 |
Single-nucleus RNA sequencing of pre-malignant liver reveals disease-associated hepatocyte state with HCC prognostic potential
Carlessi R, Denisenko E, Boslem E, Köhn-Gaone J, Main N, Abu Bakar ND, Shirolkar GD, Jones M, Beasley AB, Poppe D, Dwyer BJ, Jackaman C, Tjiam MC, Lister R, Karin M, Fallowfield JA, Kendall TJ, Forbes SJ, Gray ES, Olynyk JK, Yeoh G, Forrest AR, Ramm GA, Febbraio MA, Tirnitz-Parker JE |
2023 | |
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid
Qin XY, Furutani Y, Yonezawa K, Shimizu N, Kato-Murayama M, Shirouzu M, Xu Y, Yamano Y, Wada A, Gailhouste L, Shrestha R, Takahashi M, Keillor JW, Su T, Yu W, Fujii S, Kagechika H, Dohmae N, Shirakami Y, Shimizu M, Masaki T, Matsuura T, Suzuki H, Kojima S |
Cell Death and Disease | 2023 |
A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d
Domènech Omella J, Cortesi EE, Verbinnen I, Remmerie M, Wu H, Cubero FJ, Roskams T, Janssens V |
Cancers | 2023 |
Chronic metabolic stress drives developmental programs and loss of tissue functions in non-transformed liver that mirror tumor states and stratify survival
Tzouanas CN, Sherman MS, Shay JE, Rubin AJ, Mead BE, Dao TT, Butzlaff T, Mana MD, Kolb KE, Walesky C, Pepe-Mooney BJ, Smith CJ, Prakadan SM, Ramseier ML, Tong EY, Joung J, Chi F, McMahon-Skates T, Winston CL, Jeong WJ, Aney KJ, Chen E, Nissim S, Zhang F, Deshpande V, Lauer GM, Yilmaz ÖH, Goessling W, Shalek AK |
2023 | |
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Ye L, Schneider JS, Ben Khaled N, Schirmacher P, Seifert C, Frey L, He Y, Geier A, De Toni EN, Zhang C, Reiter FP |
Liver Cancer | 2023 |
Liver is a primary source of insulin-like growth factor-1 in skin wound healing
R Roberts, J Cavalcante-Silva, R Kineman, T Koh |
Journal of Endocrinology | 2022 |
Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances
B Cucarull, A Tutusaus, P Rider, T Hernáez-Alsina, C Cuño, P de Frutos, A Colell, M Marí, A Morales |
Cancers | 2022 |
Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds
H Mai, H Xie, M Luo, J Hou, J Chen, J Hou, D Jiang |
Cancers | 2022 |
Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis
Y Liu, S Zhuo, Y Zhou, L Ma, Z Sun, X Wu, X Wang, B Gao, Y Yang |
Journal of Hepatology | 2022 |
Cellular origins of regenerating liver and hepatocellular carcinoma
Á Holczbauer, K Wangensteen, S Shin |
2022 | |
Opposing roles of HDAC6 in liver regeneration and hepatocarcinogenesis
Phorl S, Memon A, Seo Y, Hoang TO, Tran TN, Nguyen LM, Lee CH, Lee WK, Lee J |
Cancer Science | 2022 |
Rare Inherited Cholestatic Disorders and Molecular Links to Hepatocarcinogenesis
Jeyaraj R, Kelly D |
Cells | 2022 |
Clinical applications of circulating tumor cells in hepatocellular carcinoma
Hua Y, Dong J, Hong J, Wang B, Yan Y, Li Z |
Frontiers in Oncology | 2022 |
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis.
Filliol A, Saito Y, Nair A, Dapito DH, Yu LX, Ravichandra A, Bhattacharjee S, Affo S, Fujiwara N, Su H, Sun Q, Savage TM, Wilson-Kanamori JR, Caviglia JM, Chin L, Chen D, Wang X, Caruso S, Kang JK, Amin AD, Wallace S, Dobie R, Yin D, Rodriguez-Fiallos OM, Yin C, Mehal A, Izar B, Friedman RA, Wells RG, Pajvani UB, Hoshida Y, Remotti HE, Arpaia N, Zucman-Rossi J, Karin M, Henderson NC, Tabas I, Schwabe RF |
Nature | 2022 |
Redox-Regulation in Cancer Stem Cells.
Lendeckel U, Wolke C |
Biomedicines | 2022 |
Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver
VJ Barthet, M Brucoli, MJ Ladds, C Nössing, C Kiourtis, AD Baudot, J OPrey, B Zunino, M Müller, S May, C Nixon, JS Long, TG Bird, KM Ryan |
Science Advances | 2021 |
Hyperpolyploidization of hepatocyte initiates preneoplastic lesion formation in the liver
H Lin, YS Huang, JM Fustin, M Doi, H Chen, HH Lai, SH Lin, YL Lee, PC King, HS Hou, HW Chen, PY Young, HW Chao |
Nature Communications | 2021 |
The immunological and metabolic landscape in primary and metastatic liver cancer
X Li, P Ramadori, D Pfister, M Seehawer, L Zender, M Heikenwalder |
Nature Reviews Cancer | 2021 |
Cell of origin in biliary tract cancers and clinical implications
A Moeini, PK Haber, D Sia |
2021 | |
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
TK Lee, XY Guan, S Ma |
Nature Reviews Gastroenterology & Hepatology | 2021 |
Dietary and Genetic Cholesterol Loading Rather Than Steatosis Promotes Liver Tumorigenesis and NASH-Driven HCC
V Ribas, LC de la Rosa, D Robles, S Núñez, P Segalés, N Insausti-Urkia, E Solsona-Vilarrasa, J Fernández-Checa, C García-Ruiz |
Cancers | 2021 |
Ssu72-HNF4α signaling axis classify the transition from steatohepatitis to hepatocellular carcinoma
HS Kim, JS Yoon, Y Jeon, EJ Park, JK Lee, S Chen, H Lee, JY Park, H Go, CW Lee |
Cell Death and Differentiation | 2021 |
Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis
S Kurosaki, H Nakagawa, Y Hayata, S Kawamura, Y Matsushita, T Yamada, K Uchino, Y Hayakawa, N Suzuki, M Hata, M Tsuboi, H Kinoshita, Y Tanaka, T Nakatsuka, Y Hirata, K Tateishi, K Koike |
2021 | |
Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice
J Baglieri, C Zhang, S Liang, X Liu, T Nishio, SB Rosenthal, D Dhar, H Su, M Cong, J Jia, M Hosseini, M Karin, T Kisseleva, DA Brenner |
The American Journal of Pathology | 2021 |
Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches
Z Farzaneh, M Vosough, T Agarwal, M Farzaneh |
Cancer Cell International | 2021 |
Non-Genomic Control of Dynamic MYCN Gene Expression in Liver Cancer
XY Qin, L Gailhouste |
Frontiers in Oncology | 2021 |
Nuclear VEGFR-2 Expression of Hepatocytes Is Involved in Hepatocyte Proliferation and Liver Regeneration During Chronic Liver Injury
AR Lee, SM Baek, SW Lee, TU Kim, JE Han, S Bae, SJ Park, TH Kim, KS Jeong, SK Choi, JK Park |
In vivo (Athens, Greece) | 2021 |
Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis
LA Broadfield, JA Duarte, R Schmieder, D Broekaert, K Veys, M Planque, K Vriens, Y Karasawa, F Napolitano, S Fujita, M Fujii, M Eto, B Holvoet, R Vangoitsenhoven, J Fernandez-Garcia, JV Elsen, J Dehairs, J Zeng, J Dooley, RA Rubio, J van Pelt, TG Grünewald, A Liston, C Mathieu, CM Deroose, JV Swinnen, D Lambrechts, D di Bernardo, S Kuroda, KD Bock, SM Fendt |
Cancer research | 2021 |
Targeting the De Novo Purine Synthesis Pathway Through Adenylosuccinate Lyase Depletion Impairs Liver Cancer Growth by Perturbing Mitochondrial Function
T Jiang, FJ SánchezRivera, YM SotoFeliciano, Q Yang, CQ Song, A Bhuatkar, CM Haynes, MT Hemann, W Xue |
Hepatology | 2021 |
The Cancer Stem Cell in Hepatocellular Carcinoma
LA Schulte, JC López-Gil, B Sainz, PC Hermann |
Cancers | 2020 |
Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features
X Cai, H Li, DE Kaplan |
Cell & Bioscience | 2020 |
FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome
F Li, P Huangyang, M Burrows, K Guo, R Riscal, J Godfrey, KE Lee, N Lin, P Lee, IA Blair, B Keith, B Li, MC Simon |
Nature Cell Biology | 2020 |
The HMGB1-RAGE axis modulates the growth of autophagy-deficient hepatic tumors
B Khambu, H Hong, S Liu, G Liu, X Chen, Z Dong, J Wan, XM Yin |
Cell Death and Disease | 2020 |
Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism
N Ali, CB Nguyen, P Chandrakesan, RF Wolf, D Qu, R May, T Goretsky, J Fazili, TA Barrett, M Li, MM Huycke, MS Bronze, CW Houchen |
Scientific Reports | 2020 |
Liver Progenitors and Adult Cell Plasticity in Hepatic Injury and Repair: Knowns and Unknowns
S Ko, JO Russell, LM Molina, SP Monga |
Annual review of pathology | 2020 |
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
L Walcher, AK Kistenmacher, H Suo, R Kitte, S Dluczek, A Strauß, AR Blaudszun, T Yevsa, S Fricke, U Kossatz-Boehlert |
Frontiers in immunology | 2020 |
The cellular origins of cancer with particular reference to the gastrointestinal tract
MR Alison |
International Journal of Experimental Pathology | 2020 |
Loss of SRSF2 triggers hepatic progenitor cell activation and tumor development in mice
C Zhang, L Shen, W Yuan, Y Liu, R Guo, Y Luo, Z Zhan, Z Xie, G Wu, W Wu, Y Feng |
2020 | |
Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features
C Zhu, YJ Ho, MA Salomao, DH Dapito, A Bartolome, RF Schwabe, JS Lee, SW Lowe, UB Pajvani |
Journal of Hepatology | 2020 |
Fate and functional roles of Prominin 1+ cells in liver injury and cancer
R Wu, S Pan, Y Chen, Y Nakano, M Li, S Balog, H Tsukamoto |
Scientific Reports | 2020 |
Oncogenic driver genes and tumor microenvironment determine the type of liver cancer
G Wang, Q Wang, N Liang, H Xue, T Yang, X Chen, Z Qiu, C Zeng, T Sun, W Yuan, C Liu, Z Chen, X He |
Cell Death and Disease | 2020 |
Somatic mutation landscape reveals differential variability of cell-of-origin for primary liver cancer
K Ha, M Fujita, R Karlić, S Yang, R Xue, C Zhang, F Bai, N Zhang, Y Hoshida, P Polak, H Nakagawa, HG Kim, H Lee |
Heliyon | 2020 |
CK19-positive Hepatocellular Carcinoma is a Characteristic Subtype
JY Zhuo, D Lu, WY Tan, SS Zheng, YQ Shen, X Xu |
Journal of Cancer | 2020 |
Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression
H Rhee, H Kim, YN Park |
Liver Cancer | 2020 |
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
C Orrù, A Perra, MA Kowalik, S Rizzolio, E Puliga, L Cabras, S Giordano, A Columbano |
Cancers | 2020 |
Adeno-Associated Virus Serotype 8-Mediated Genetic Labeling of Cholangiocytes in the Neonatal Murine Liver
S Lee, P Zhou, S Whyte, S Shin |
Pharmaceutics | 2020 |
Predicting miRNA targets for hepatocellular carcinoma with an integrated method
Y Shi, T Wen, D Xiao, L Dai, J Song |
Translational cancer research | 2020 |
Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Tumors Following Chronic Liver Injury
Y Lin, S Zhang, M Zhu, T Lu, K Chen, Z Wen, S Wang, G Xiao, D Luo, Y Jia, L Li, M MacConmara, Y Hoshida, A Singal, A Yopp, T Wang, H Zhu |
Gastroenterology | 2020 |
Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice
L Zong, H Peng, C Sun, F Li, M Zheng, Y Chen, H Wei, R Sun, Z Tian |
Nature Communications | 2019 |
Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis
SK Kim, H Takeda, A Takai, T Matsumoto, N Kakiuchi, A Yokoyama, K Yoshida, T Kaido, S Uemoto, S Minamiguchi, H Haga, Y Shiraishi, S Miyano, H Seno, S Ogawa, H Marusawa |
Journal of Gastroenterology | 2019 |
Comparison of the Opn-CreER and Ck19-CreER Drivers in Bile Ducts of Normal and Injured Mouse Livers
Lesaffer, Verboven, V Huffel, Moya, van Grunsven, Leclercq, Lemaigre, Halder |
Cells | 2019 |
The Molecular Chaperone Heat Shock Protein 70 Controls Liver Cancer Initiation and Progression by Regulating Adaptive DNA Damage and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling Pathways
W Cho, X Jin, J Pang, Y Wang, NF Mivechi, D Moskophidis |
Molecular and cellular biology | 2019 |
The evolving landscape of precision medicine in primary liver cancer
SP Martin, XW Wang |
Hepatic Oncology | 2019 |
HDAC3 deficiency promotes liver cancer through a defect in H3K9ac/H3K9me3 transition
H Ji, Y Zhou, X Zhuang, Y Zhu, Z Wu, Y Lu, S Li, Y Zeng, QR Lu, Y Huo, Y Shi, H Bu |
Cancer research | 2019 |
Hepatic Cellular Distribution of Silica Nanoparticles by Surface Energy Modification
AR Lee, K Nam, BJ Lee, SW Lee, SM Baek, JS Bang, SK Choi, SJ Park, TH Kim, KS Jeong, DY Lee, JK Park |
International journal of molecular sciences | 2019 |
IGF2 mRNA Binding Protein 2 Transgenic Mice Are More Prone to Develop a Ductular Reaction and to Progress Toward Cirrhosis
B Czepukojc, A Abuhaliema, A Barghash, S Tierling, N Naß, Y Simon, C Körbel, C Cadenas, N van Hul, A Sachinidis, JG Hengstler, V Helms, MW Laschke, J Walter, J Haybaeck, I Leclercq, AK Kiemer, SM Kessler |
Frontiers in Medicine | 2019 |
Lgr5 + pericentral hepatocytes are self-maintained in normal liver regeneration and susceptible to hepatocarcinogenesis
CH Ang, SH Hsu, F Guo, CT Tan, VC Yu, JE Visvader, PK Chow, NY Fu |
Proceedings of the National Academy of Sciences | 2019 |
SIRT1 in the Development and Treatment of Hepatocellular Carcinoma
M Farcas, AA Gavrea, D Gulei, C Ionescu, A Irimie, CS Catana, I Berindan-Neagoe |
Frontiers in Nutrition | 2019 |
Cell Biology and Translational Medicine, Volume 7: Stem Cells and Therapy: Emerging Approaches
K Turksen |
2019 | |
Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cells
Z Dai, G Song, A Balakrishnan, T Yang, Q Yuan, S Möbus, AC Weiss, M Bentler, J Zhu, X Jiang, X Shen, H Bantel, E Jaeckel, A Kispert, A Vogel, A Saborowski, H Büning, M Manns, T Cantz, M Ott, AD Sharma |
Gut | 2019 |
Kinetic modelling of quantitative proteome data predicts metabolic reprogramming of liver cancer
N Berndt, A Egners, G Mastrobuoni, O Vvedenskaya, A Fragoulis, A Dugourd, S Bulik, M Pietzke, C Bielow, R van Gassel, SW Damink, M Erdem, J Saez-Rodriguez, HG Holzhütter, S Kempa, T Cramer |
British Journal of Cancer | 2019 |
HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis
Céline Hernandez, Peter Huebener, Jean-Philippe Pradere, Daniel Antoine, Richard A Friedman, Robert Schwabe |
Journal of Clinical Investigation | 2018 |
HMGB1 Promotes Ductular Reaction and Tumorigenesis in Autophagy-deficient Livers
Bilon Khambu, Nazmul Huda, Xiaoyun Chen, Daniel Antoine, Yong Li, Guoli Dai, Ulrike Kohler, Wei-Xing Zong, Satoshi Waguri, Sabine Werner, Tim Oury, Zheng Dong, Xiao-Ming Yin |
Journal of Clinical Investigation | 2018 |
Hypercholesterolemia induces T cell expansion in humanized immune mice
Jonathan D Proto, Amanda Doran, Manikandan Subramanian, Hui Wang, Mingyou Zhang, Erdi Sozen, Christina Rymond, George Kuriakose, Vivette D'Agati, Robert Winchester, Megan Sykes, Yong-Guang Yang, Ira Tabas |
Journal of Clinical Investigation | 2018 |
Animal models to study bile acid metabolism
J Li, PA Dawson |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2018 |
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
DS Ghorpade, L Ozcan, Z Zheng, SM Nicoloro, Y Shen, E Chen, M Blüher, MP Czech, I Tabas |
Nature | 2018 |
Differentiation-inducing therapeutic effect of Notch inhibition in reversing malignant transformation of liver normal stem cells via MET
H Luo, W Liu, H Liang, H Yan, N Lin, D Li, T Wang, L Tang |
Oncotarget | 2018 |
Animal models of biliary injury and altered bile acid metabolism
V Mariotti, M Strazzabosco, L Fabris, DF Calvisi |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2018 |
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance
M Xu, S Fang, J Song, M Chen, Q Zhang, Q Weng, X Fan, W Chen, X Wu, F Wu, J Tu, Z Zhao, J Ji |
Cell Death and Disease | 2018 |
Liver Regeneration: Different Sub-Populations of Parenchymal Cells at Play Choreographed by an Injury-Specific Microenvironment
R Manco, IA Leclercq, LA Clerbaux |
International journal of molecular sciences | 2018 |
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
C Zhu, KJ Kim, X Wang, A Bartolome, M Salomao, P Dongiovanni, M Meroni, MJ Graham, KP Yates, AM Diehl, RF Schwabe, I Tabas, L Valenti, JE Lavine, UB Pajvani |
Science Translational Medicine | 2018 |
Pregnane X Receptor Regulates Liver Size and Liver Cell Fate by Yes-Associated Protein Activation in Mice: HEPATOLOGY
Y Jiang, D Feng, X Ma, S Fan, Y Gao, K Fu, Y Wang, J Sun, X Yao, C Liu, H Zhang, L Xu, A Liu, FJ Gonzalez, Y Yang, B Gao, M Huang, H Bi |
Hepatology | 2018 |
An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1
Z Zheng, L Nayak, W Wang, A Yurdagul, X Wang, B Cai, S Lapping, L Ozcan, R Ramakrishnan, RG Pestell, MK Jain, I Tabas |
Blood | 2018 |
Liver and Pancreas: Do Similar Embryonic Development and Tissue Organization Lead to Similar Mechanisms of Tumorigenesis?
E Ghurburrun, I Borbath, FP Lemaigre, P Jacquemin |
Gene expression | 2018 |
The Role of Cancer-Associated Fibroblasts and Fibrosisin Liver Cancer
S Affo, LX Yu, RF Schwabe |
Annual review of pathology | 2017 |
Hepatocyte-specific Smad7 deletion accelerates DEN-induced HCC via activation of STAT3 signaling in mice
T Feng, J Dzieran, X Yuan, A Dropmann, T Maass, A Teufel, S Marhenke, T Gaiser, F Rückert, I Kleiter, S Kanzler, MP Ebert, A Vogel, P Dijke, S Dooley, NM Meindl-Beinker |
Oncogenesis | 2017 |
Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis
JE Yoo, YJ Kim, H Rhee, H Kim, EY Ahn, JS Choi, M Roncalli, YN Park, T Yamashita |
PloS one | 2017 |
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells
KS Tummala, M Brandt, A Teijeiro, O Graña, RF Schwabe, C Perna, N Djouder |
Cell Reports | 2017 |
Road to stemness in hepatocellular carcinoma
TN Flores-Téllez, S Villa-Treviño, C Piña-Vázquez |
World journal of gastroenterology : WJG | 2017 |
Loss of liver-specific and sexually dimorphic gene expression by aryl hydrocarbon receptor activation in C57BL/6 mice
R Nault, KA Fader, JR Harkema, T Zacharewski, H Guillou |
PloS one | 2017 |
Global Analysis of Plasma Lipids Identifies Liver-Derived Acylcarnitines as a Fuel Source for Brown Fat Thermogenesis
J Simcox, G Geoghegan, JA Maschek, CL Bensard, M Pasquali, R Miao, S Lee, L Jiang, I Huck, EE Kershaw, AJ Donato, U Apte, N Longo, J Rutter, R Schreiber, R Zechner, J Cox, CJ Villanueva |
Cell Metabolism | 2017 |
The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
O Govaere, M Petz, J Wouters, YP Vandewynckel, EJ Scott, B Topal, F Nevens, C Verslype, QM Anstee, HV Vlierberghe, W Mikulits, T Roskams |
Oncogene | 2017 |
TET-Catalyzed 5-Hydroxymethylation Precedes HNF4A Promoter Choice during Differentiation of Bipotent Liver Progenitors
PB Ancey, S Ecsedi, MP Lambert, FR Talukdar, MP Cros, D Glaise, DM Narvaez, V Chauvet, Z Herceg, A Corlu, H Hernandez-Vargas |
Stem Cell Reports | 2017 |
Hepatocyte selection medium-enriched hepatocellular carcinoma cells are positive for α-fetoprotein and CD44
M Tomizawa, F Shinozaki, Y Motoyoshi, T Sugiyama, S Yamamoto, N Ishige |
Oncology Letters | 2017 |
FOXA2 alleviates CCl4-induced liver fibrosis by protecting hepatocytes in mice
W Wang, LJ Yao, W Shen, K Ding, PM Shi, F Chen, J He, J Ding, X Zhang, WF Xie |
Scientific Reports | 2017 |
Fate tracing of hepatocytes in mouse liver
X Gu, D Huang, L Ci, J Shi, M Zhang, H Yang, Z Wang, Z Sheng, R Sun, J Fei |
Scientific Reports | 2017 |
Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration
S Zhang, LH Nguyen, K Zhou, HC Tu, A Sehgal, I Nassour, L Li, P Gopal, J Goodman, AG Singal, A Yopp, Y Zhang, DJ Siegwart, H Zhu |
Gastroenterology | 2017 |
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.
Castelli G, Pelosi E, Testa U |
Cancers | 2017 |
Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+- liver cells deficient for p53 and Rb
RB Matondo, MJ Toussaint, KM Govaert, LD van Vuuren, S Nantasanti, MW Nijkamp, SK Pandit, PC Tooten, MH Koster, K Holleman, A Schot, G Gu, B Spee, T Roskams, IB Rinkes, B Schotanus, O Kranenburg, A Bruin |
Oncotarget | 2016 |
Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice
S Shin, KJ Wangensteen, M Teta-Bissett, YJ Wang, E Mosleh-Shirazi, EL Buza, LE Greenbaum, KH Kaestner |
Hepatology | 2016 |
Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population
T Duarte-Salles, S Misra, M Stepien, A Plymoth, D Muller, K Overvad, A Olsen, A Tjonneland, L Baglietto, G Severi, MC Boutron-Ruault, R Turzanski-Fortner, R Kaaks, H Boeing, K Aleksandrova, A Trichopoulou, P Lagiou, C Bamia, V Pala, D Palli, A Mattiello, R Tumino, A Naccarati, HB Bueno-de-Mesquita, PH Peeters, E Weiderpass, JR Quiros, A Agudo, E Sanchez-Cantalejo, E Ardanaz, D Gavrila, M Dorronsoro, M Werner, O Hemmingsson, B Ohlsson, K Sjo berg, NJ Wareham, KT Khaw, KE Bradbury, MJ Gunter, AJ Cross, E Riboli, M Jenab, P Hainaut, L Beretta |
Cancer prevention research (Philadelphia, Pa.) | 2016 |
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
X Wang, Z Zheng, JM Caviglia, KE Corey, TM Herfel, B Cai, R Masia, RT Chung, JH Lefkowitch, RF Schwabe, I Tabas |
Cell Metabolism | 2016 |
Differentiation and Inflammation: ‘Best Enemies’ in Gastrointestinal Carcinogenesis
NM Krah, LC Murtaugh |
Trends in Cancer | 2016 |
Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis
Eliene Bogaerts, Annelies Paridaens, Xavier Verhelst, Peter Carmeliet, Anja Geerts, Hans Van Vlierberghe, Lindsey Devisscher |
EXCLI J | 2016 |
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Sia D, Villanueva A, Friedman SL, Llovet JM |
Gastroenterology | 2016 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |